small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (353)
  • Capabilities (79)
  • Experience (78)
  • Insights & News (3,501)
  • Other Results (113)

Professionals 353 results

Charlie Papavizas
Charlie Papavizas
Partner
  • Washington, DC
Email
+1 202-282-5732
vCard

Partner

  • Washington, DC
Reid Smith
Reid Smith
Partner
  • Chicago
Email
+1 312-558-7241
vCard

Partner

  • Chicago
Cari Stinebower
Cari Stinebower
Partner
  • Washington, DC
Email
+1 202-282-5788
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 79 results

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Practice Area

Patent Litigation

Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022)....Read more

Industry

Maritime & Admiralty

Experience 78 results

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

May 15, 2025

Winston Secures Federal Circuit Victory for Snap Axing Image-Presentation Patents on the Pleadings

Experience

|

May 9, 2025

An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner

View All Experience

Insights & News 3,501 results

Direct Sellers Update: Regulation, Law & Policy

|

August 11, 2025

|

10+ Min Read

Robinson-Patman Act Enforcement in the Direct-Selling Industry: A Clearer Look

With renewed enforcement of the Robinson-Patman Act against illegal price discrimination looming, direct-selling companies should reassess their pricing models. The FTC has made clear that tiered wholesale pricing, which gives higher-ranked distributors more favorable terms than their lower-ranked counterparts, can create significant legal risks under antitrust laws.

Competition Corner

|

August 11, 2025

|

6 Min Read

Epic v. Google: Setting the Bar for Affirmative Antitrust Remedies in the Digital Age

The July 2025 decision by the Ninth Circuit Court of Appeals in Epic Games v. Google marks a landmark development in the ongoing evolution of antitrust remedies for unilateral conduct in the technology sector. The court’s willingness to affirm not just prohibitory, but also mandatory, forward-looking injunctions—requiring Google to take affirmative steps to open its Android app ecosystem to competition—signals a vigorous approach to restoring competition in digital platforms.

Client Alert

|

August 11, 2025

|

9 Min Read

The Current Debate about “Debanking”: Navigating Legal, Regulatory, and Reputational Challenges for Financial Institutions

Debanking—closing accounts or refusing to open accounts for customers perceived to be high risk—has become a hotly debated topic in recent years among groups on both sides of the political aisle. The debate involves allegations that banks have improperly debanked customers for political, rather than risk-based, reasons. Such accusations have shined a spotlight on banks’ account management practices, resulting in changes to regulatory practices and a new executive order from President Trump requiring additional regulatory changes and investigations. All of which will mean increased risk for financial institutions....Read more
View All Insights & News

Other Results 113 results

Law Glossary

What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?

There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation....Read more

Law Glossary

What Is the Approval Process for Generic Drugs?

Approval for generic drugs are governed by the Hatch-Waxman Act. The Hatch-Waxman Act provides the framework for an applicant to demonstrate that its proposed generic product is bioequivalent to the brand-name drug....Read more

Site Content

The Corporate Transparency Act
Task Force

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising